Author

Sarah D. Grieder

German Cancer Research CenterORCID 0000-0002-5317-8553Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander Eckehart UrbaniD· 1 shared Alexis MitelpunktiD· 1 shared Bradley J. Swanson· 1 shared Bruce J. AronowiD· 1 shared Carolin PurmanniD· 1 shared ChangHui PakiD· 1 shared Charly JehannoiD· 1 shared Douglas F. LevinsoniD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alexander Eckehart UrbanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The glutamine-aspartate metabolic tradeoff between fast growth and metabolic flexibility.

Karin Ortmayr, Meret Ringwald, Laurentz Schuhknecht, Sébastien Dubuis, Eleni Paunossis, Martina Blaesi, Charly Jehanno, Sarah D. Grieder, Mohamed Bentires‐Alj, Moritz Mall, Mattia Zampieri

This study identifies a metabolic tradeoff between fast growth and flexibility in cancer cells and stem cells by analyzing glutamine and aspartate metabolism.

Genome biology · Oct 27, 2026Peer-reviewedCancer Biology

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons

ChangHui Pak, Tamás Dankó, Vincent R. Mirabella, Jinzhao Wang, Yingfei Liu, Madhuri Vangipuram, Sarah D. Grieder, Xianglong Zhang, Thomas Ward, Yu‐Wen Alvin Huang, Kang Jin, Phillip J. Dexheimer, Eric E. Bardes, Alexis Mitelpunkt, Junyi Ma, , Thomas Christian Südhof

This study validates that heterozygous NRXN1 deletions impair neurotransmitter release in human neurons across multiple labs, suggesting a human-specific synaptic dysfunction relevant for schizophrenia drug discovery.

Proceedings of the National Academy of Sciences · May 25, 2021Peer-reviewedNeuroscience